A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity
Huntington's disease (HD) represents an important model for neurodegenerative disorders and proteinopathies. It is mainly caused by cytotoxicity of the mutant huntingtin protein (Htt) with an expanded polyQ stretch. While Htt is ubiquitously expressed, HD is characterized by selective neurodege...
Main Authors: | Yuwei Yao, Xiaotian Cui, Ismael Al-Ramahi, Xiaoli Sun, Bo Li, Jiapeng Hou, Marian Difiglia, James Palacino, Zhi-Ying Wu, Lixiang Ma, Juan Botas, Boxun Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2015-03-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/05449 |
Similar Items
-
Rapamycin reduces neuronal mutant huntingtin aggregation and ameliorates locomotor performance in Drosophila
by: Jonathan R. Roth, et al.
Published: (2023-09-01) -
Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo
by: Delphine Charvin, et al.
Published: (2008-01-01) -
Emerging Roles of Exosomes in Huntington’s Disease
by: Hanadi Ananbeh, et al.
Published: (2021-04-01) -
Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates
by: Philippe Gosset, et al.
Published: (2020-07-01) -
Length-Dependent Structural Transformations of Huntingtin PolyQ Domain Upon Binding to 2D-Nanomaterials
by: Mei Feng, et al.
Published: (2020-04-01)